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An old debate has been revisited using a 
novel technique (Schwender et al., 2012): is 
genetic predisposition or environmental ex-
posure more relevant for cancer risk? In this 
context urinary bladder cancer represents a 
particularly well-studied example (Golka et 
al., 2012a, b; Roth et al., 2012; Ovsianni-
kov et al., 2012). The environmental influ-
ence on bladder cancer risk has been clearly 
documented for cigarette smoking and oc-
cupational exposure to aromatic amines and 
polycyclic aromatic hydrocarbons - both 
representing the most important factors 
(Golka et al., 2009; 2012a, b). Recently, 
several single nucleotide polymorphisms 
have also been identified that are associated 
with urinary bladder cancer risk, all of 
which have been confirmed in independent 
follow-up studies (Kiemeney et al., 2008, 
2010; Rothman et al., 2010; Rafnar et al., 
2011; Lehmann et al., 2010; Golka et al., 
2011; Selinski et al., 2012a, b; Binder et al., 
2012). In total 13 novel SNPs have been 
identified, as recently summarized (Selinski 
et al., 2012a, b). 
Using a novel technique for interaction 
analysis Schwender et al. (2012) have now 
calculated an ‘overall genetic risk’ based on 
the interactions of the high risk alleles of 
recently identified genetic variants. The 
highest stable combination resulted in an 
odds ratio of 2.0, a ratio that is still lower 
than the odds ratio of cigarette smoking 
which was 3.28 for the current smokers of 
the study population. However, both odds 
ratios are still low compared to some of the 
worst cases of occupational exposure, for 
example an odds ratio of 5-200 has been 
reported for workers exposed to beta-
naphtylamine, and 38-90 for 4-chloro-o-
toluidine-exposed individuals. The study of 
Schwender et al. (2012) is of interest to all 
who interested in the direct comparison of 
environmental and genetic influences on 
cancer risk. 
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